157 related articles for article (PubMed ID: 21077034)
1. [Updated recommendations on systemic treatment of non-small cell lung cancer and malignant pleural mesothelioma].
Jassem J; Biernat W; Drosik K; Dziadziuszko R; Kordek R; Kozielski J; Kowalski DM; Krzakowski M; Nikliński J; Olszewski W; Orłowski T; Ramlau R; Roszkowski-Śliż K; Rzyman W
Pneumonol Alergol Pol; 2010; 78(6):418-31. PubMed ID: 21077034
[No Abstract] [Full Text] [Related]
2. [Recommendations on systemic treatment of non-small cell lung cancer and maligant pleural mesothelioma].
Krzakowski M
Pneumonol Alergol Pol; 2010; 78(6):384-5. PubMed ID: 21077029
[No Abstract] [Full Text] [Related]
3. [Systemic treatment of non-small cell lung cancer--recommendations based on the results of reliable clinical trials].
Jassem J; Drosik K; Dziadziuszko R; Kordek R; Kozielski J; Kowalski D; Krzakowski M; Nikliński J; Olszewski W; Orłowski T; Ramlau R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2008; 76(1):44-52. PubMed ID: 18283654
[TBL] [Abstract][Full Text] [Related]
4. Management of malignant pleural mesothelioma.
West SD; Lee YC
Clin Chest Med; 2006 Jun; 27(2):335-54. PubMed ID: 16716822
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of malignant pleural mesothelioma--present status and future view].
Yano T; Morodomi Y; Ito K; Miura N; Takenaka T; Kawano D; Shoji F; Maehara Y
Fukuoka Igaku Zasshi; 2008 Apr; 99(4):74-9. PubMed ID: 18646592
[No Abstract] [Full Text] [Related]
6. [Malignant pleural mesothelioma in 1997].
Viallat JR; Boutin C; Kasseyet S
Schweiz Med Wochenschr; 1997 Oct; 127(41):1707-11. PubMed ID: 9441378
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of malignant pleural mesothelioma].
Köksal D; Beder S
Tuberk Toraks; 2003; 51(3):310-9. PubMed ID: 15143412
[No Abstract] [Full Text] [Related]
8. Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy.
Bölükbas S; Manegold C; Eberlein M; Bergmann T; Fisseler-Eckhoff A; Schirren J
Lung Cancer; 2011 Jan; 71(1):75-81. PubMed ID: 19765853
[TBL] [Abstract][Full Text] [Related]
9. Future developments in the management of malignant pleural mesothelioma.
Zucali PA; De Vincenzo F; Simonelli M; Santoro A
Expert Rev Anticancer Ther; 2009 Apr; 9(4):453-67. PubMed ID: 19374599
[TBL] [Abstract][Full Text] [Related]
10. Current concepts in malignant pleural mesothelioma.
Kaufman AJ; Pass HI
Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
[TBL] [Abstract][Full Text] [Related]
12. The pathology associated with therapeutic procedures in malignant mesothelioma.
Attanoos RL; Gibbs AR
Histopathology; 2004 Oct; 45(4):393-7. PubMed ID: 15469478
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Rusch VW
Eur J Cardiothorac Surg; 2007 Mar; 31(3):534-5. PubMed ID: 17267238
[No Abstract] [Full Text] [Related]
14. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Stahel RA; Weder W; Lievens Y; Felip E;
Ann Oncol; 2010 May; 21 Suppl 5():v126-8. PubMed ID: 20555061
[No Abstract] [Full Text] [Related]
15. [Therapeutic options in malignant pleural mesothelioma].
Serke M; Loddenkemper R
Pneumologie; 2005 May; 59(5):337-48. PubMed ID: 15902599
[TBL] [Abstract][Full Text] [Related]
16. Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
Aigner C; Hoda MA; Lang G; Taghavi S; Marta G; Klepetko W
Eur J Cardiothorac Surg; 2008 Jul; 34(1):204-7. PubMed ID: 18407510
[TBL] [Abstract][Full Text] [Related]
17. [Recommendations for the management of malignant pleural mesothelioma. The SPLF goes forward].
Godard P
Rev Mal Respir; 2006 Sep; 23(4 Pt 3):11S3-4. PubMed ID: 17370374
[No Abstract] [Full Text] [Related]
18. Neoadjuvant chemotherapy in malignant pleural mesothelioma.
Stahel R; Weder W
Lung Cancer; 2005 Jul; 49 Suppl 1():S69-70. PubMed ID: 15950804
[No Abstract] [Full Text] [Related]
19. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer.
Freeman RK; Van Woerkom JM; Vyverberg A; Ascioti AJ
Eur J Cardiothorac Surg; 2010 Jul; 38(1):1-5. PubMed ID: 20206544
[TBL] [Abstract][Full Text] [Related]
20. [The experts' conference of the Société de Pneumologie de Langue Française (SPLF) on malignant pleural mesothelioma (MPM): useful and necessary recommendations].
Scherpereel A
Rev Mal Respir; 2006 Sep; 23(4 Pt 3):11S5-6. PubMed ID: 17370375
[No Abstract] [Full Text] [Related]
[Next] [New Search]
